AVIENCE BIOMEDICALS (AVIENCE) Share Price Fall Streak: second straight lower close

AVIENCE BIOMEDICALS Share Price Fall Streak has now extended into a second straight session, with the stock slipping 18.54% across the run from Rs 359.7 to Rs 293. According to Univest data, the price pattern is confirmed, but no company-specific catalyst is established. The latest leg took the stock down 9.5% for the day, and the move matters because it follows another lower close rather than standing alone as an isolated swing.

AVIENCE BIOMEDICALS Share Price Fall Streak also needs to be read in the context of a Rs 177.58 crore market capitalisation. For a Micro Cap name, a run of consecutive lower closes can change how traders and long-term readers interpret the same price move. A single-day decline tells only one part of the story; a second straight session shows the follow-through that investors usually track in Aviance Biomedicals stock news and stock analysis.

AVIENCE BIOMEDICALS (AVIENCE) Share Price Fall Streak: Consecutive Decline Analysis

Metric	Value
Current Price	Rs 293
Previous Close	Rs 323.75
Today's Move	-Rs 30.75 (-9.5%)
Open	Rs 316.2
High	Rs 316.2
Low	Rs 293
Market Capitalisation	Rs 177.58 crore

The latest AVIENCE BIOMEDICALS Share Price Fall Streak session opened at Rs 316.2, matched the day's high at Rs 316.2, touched a low of Rs 293 and was last traded at Rs 293 versus the previous close of Rs 323.75. That translates into a fall of Rs 30.75, or 9.5%, in the latest trade window. The stock therefore spent the full range below the open after the initial print, which keeps the focus on the lower close rather than on any intraday rebound.

AVIENCE BIOMEDICALS Share Price Fall Streak leaves Aviance Biomedicals valued at Rs 177.58 crore in the Micro Cap category. The gap between the open and the low is small because the session began near the upper end of the range and then moved down to the lowest print. The key point for readers is that the second straight session added to the earlier drop, so the discussion now shifts from one day of weakness to the shape of the streak itself. That sets up the fundamental lens on what the valuation and return ratios look like after the move.

What the Consecutive Declines Show

AVIENCE BIOMEDICALS Share Price Fall Streak is notable because the decline is cumulative, not just daily. The stock has now fallen 18.54% since the streak started from Rs 359.7 on 01 October 2026, which gives readers a clearer picture of the run than the latest 9.5% move alone. When a stock records a second straight lower session, the market reads the sequence as a pattern of weakness rather than a one-off swing.

That pattern matters for Aviance Biomedicals because the price base has shifted lower in a short span while the business ratios have not changed across the streak. For readers following the AVIENCE BIOMEDICALS Share Price Fall Streak, the important question is not whether the day move was sharp, but how the repeated lower closes alter the valuation frame. According to latest Univest figures, the same earnings and book-value base now sits behind a lower share price, which is why the next sections focus on fundamentals, sector context and peer positioning.

AVIENCE BIOMEDICALS (AVIENCE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 177.58 crore
P/E Ratio	20.29x
P/B Ratio	3.35x
ROE	49.9%
ROCE	34.16%
EPS	Rs 15.96
Book Value Per Share	Rs 96.66
Dividend Yield	0%

AVIENCE BIOMEDICALS (AVIENCE) fundamental metrics show P/E 20.29x, P/B 3.35x, ROE 49.9%, ROCE 34.16%. These figures provide context only and are not a buy or sell signal.

AVIENCE BIOMEDICALS has a market capitalisation of Rs 177.58 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 20.29x, P/B at 3.35x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 49.9% and ROCE of 34.16%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.96, book value per share of Rs 96.66, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 34.51x, median ROE of 13.4%, median ROCE of 14.55%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Medical Equipment/Supplies/Accessories
Benchmark Scope	same industry
Company P/E Ratio	20.29x
Benchmark Median P/E	34.51x
Benchmark Average P/E	91.32x
Benchmark P/E Range	7.55x to 1,027.7x
Company P/B Ratio	3.35x
Benchmark Median P/B	3.59x
Benchmark Average P/B	3.89x
Company ROE	49.9%
Benchmark Median ROE	13.4%
Benchmark Average ROE	16.07%
Company ROCE	34.16%
Benchmark Median ROCE	14.55%
Benchmark Average ROCE	17.26%
Company Market Capitalisation	Rs 177.58 crore
Benchmark Median Market Cap	Rs 178.19 crore
Benchmark Average Market Cap	Rs 6,568.47 crore

AVIENCE BIOMEDICALS (AVIENCE) operates in the Healthcare sector, within the Medical Equipment/Supplies/Accessories industry.

AVIENCE BIOMEDICALS (AVIENCE) has a P/E ratio of 20.29x, which is below the benchmark median of 34.51x, a difference of -41.21%. On its own, the P/E gap is a valuation reference point, not a trading call.

AVIENCE BIOMEDICALS (AVIENCE) has a ROE of 49.9%, which is above the benchmark median of 13.4%, a difference of +272.39%. AVIENCE BIOMEDICALS (AVIENCE) has a ROCE of 34.16%, which is above the benchmark median of 14.55%, a difference of +134.78%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
LENSKART SOLUTIONS	LENSKART	1,20,264.32	183.51	13.45	6.85	12.55
Poly Medicure	POLYMED	16,606.56	52.71	5.22	10.94	14.05
Q-LINE BIOTECH	QLINE	1,542.23	27.68	3.16	25.55	22.23
3B Blackbio Dx	3BBLACKBIO	1,420.26	25.58	4.26	20.22	25.9
LAXMI DENTAL	LAXMIDENTL	1,065.92	34.51	4.34	11.95	13.29

AVIENCE BIOMEDICALS (AVIENCE) has a P/E ratio of 20.29x compared with the displayed peer median of 34.51x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 49.9% compares with a peer median of 11.95% across the companies shown in the table. ROCE stood at 34.16% versus the displayed peer median of 14.05%, providing a capital-efficiency comparison. AVIENCE BIOMEDICALS (AVIENCE) has a market capitalisation of Rs 177.58 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching AVIENCE BIOMEDICALS

• The AVIENCE BIOMEDICALS Share Price Fall Streak has now run for a second straight session, so the pattern is more than a one-day dip.
• The stock is down 18.54% across the streak, which gives the move a cumulative frame for Aviance Biomedicals share price today.
• P/E at 20.29 is below the industry median, while P/B at 3.35 sits close to the benchmark median.
• ROE of 49.9% and ROCE of 34.16% remain the strongest numbers in the peer set shown.
• Market cap of Rs 177.58 crore places the company in the Micro Cap category, which keeps price moves closely watched.

About AVIENCE BIOMEDICALS

Aviance Biomedicals operates in Healthcare, specifically the Medical Equipment/Supplies/Accessories industry. For readers tracking the AVIENCE BIOMEDICALS Share Price Fall Streak, the business context is straightforward: the company sits in a segment where product demand, pricing and execution can influence valuation sensitivity. The latest numbers show a small company by market value but one with strong return ratios on the latest Univest figures.

That matters because the AVIENCE BIOMEDICALS Share Price Fall Streak is being judged against a business that still shows solid ROE, ROCE, EPS and book value on the latest snapshot. The company description is therefore best read as context for price action rather than as a standalone narrative about expansion or demand.

Track AVIENCE BIOMEDICALS Share Price on Univest

Use Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Readers can track the AVIENCE BIOMEDICALS Share Price Fall Streak alongside live share price, valuation ratios, 52-week levels and market insights on Univest. That makes it easier to compare the latest move with the company’s fundamental ratios, sector benchmark and peer position in one place.

For Aviance Biomedicals stock news and stock analysis, Univest also keeps the latest share price update available for quick reference. If the streak continues or the price stabilises, those numbers will be the first place most readers check.

Frequently Asked Questions

Why did AVIENCE BIOMEDICALS share price fall today?

Ans. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The stock fell 9.5% to Rs 293 and extended the AVIENCE BIOMEDICALS Share Price Fall Streak into a second straight session.

What is the current AVIENCE BIOMEDICALS share price?

Ans. The latest AVIENCE BIOMEDICALS Share Price Fall Streak leaves the stock at Rs 293. That is below the previous close of Rs 323.75 and sits after a cumulative 18.54% decline across the two-session run.

How much did AVIENCE BIOMEDICALS fall today?

Ans. AVIENCE BIOMEDICALS declined by Rs 30.75, or 9.5%, in the latest trade window. The move added to the AVIENCE BIOMEDICALS Share Price Fall Streak that began from Rs 359.7 on 01 October 2026.

What does the streak in AVIENCE BIOMEDICALS share price indicate?

Ans. Two consecutive lower closes point to a short run of weakness rather than a single-day move. For the AVIENCE BIOMEDICALS Share Price Fall Streak, the cumulative drop of 18.54% is the key number to watch.

How is AVIENCE BIOMEDICALS valued after the decline?

Ans. The stock trades at a P/E of 20.29 and a P/B of 3.35. After the AVIENCE BIOMEDICALS Share Price Fall Streak, those multiples reflect the lower price against an unchanged EPS of Rs 15.96 and book value of Rs.

How does AVIENCE BIOMEDICALS compare with sector benchmarks?

Ans. Its P/E is below the industry median of 34.51 and its P/B is slightly below the median of 3.59. In the AVIENCE BIOMEDICALS Share Price Fall Streak, ROE of 49.9% and ROCE of 34.16% remain above the benchmark medians.

How does AVIENCE BIOMEDICALS compare with listed peers?

Ans. The company’s P/E is below most peers shown, and its ROE and ROCE are higher than each peer in the list. The AVIENCE BIOMEDICALS Share Price Fall Streak therefore changes price, not the relative return profile.

What should investors watch next in AVIENCE BIOMEDICALS share price?

Ans. Investors should watch whether the stock can stabilise after the second straight session and how the valuation frame behaves around Rs 293. For the AVIENCE BIOMEDICALS Share Price Fall Streak, the next update is mainly about price action and.